日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combining sodium-glucose co-transporter-2 inhibitor with mesenchymal stem cells and brown adipose tissue (BAT) and white adipose tissue (WAT) transplantation to mitigate the progression of diabetic kidney disease: a pre-clinical approach.

将钠-葡萄糖协同转运蛋白-2抑制剂与间充质干细胞和棕色脂肪组织(BAT)和白色脂肪组织(WAT)移植相结合,以减轻糖尿病肾病的进展:一种临床前方法

Beyerstedt Stephany, Franco Marcella L, Carlos Alanah K G, Arjona Jaqueline, Josefi-Rocha Gleice R, Barbosa Bruno S, Balby-Rocha Maria Theresa A, da Silva Andrei Furlan, Alves Tuany Marques Reiter, Mariano Melise Oliveira, Klein Maria Clara Soares, Rangel Érika Bevilaqua

Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells

间充质干细胞治疗糖尿病肾病:同基因、自体、异基因和异种细胞研究综述

Sávio-Silva, Christian; Beyerstedt, Stephany; Soinski-Sousa, Poliana E; Casaro, Expedito B; Balby-Rocha, Maria Theresa A; Simplício-Filho, Antônio; Alves-Silva, Jamille; Rangel, Érika B